Trials / Conditions / Metastatic Digestive System Neuroendocrine Tumor G1
Metastatic Digestive System Neuroendocrine Tumor G1
6 registered clinical trials studyying Metastatic Digestive System Neuroendocrine Tumor G1 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectab NCT05773274 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors NCT03375320 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors NCT01841736 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N NCT01204476 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer NCT00454363 | National Cancer Institute (NCI) | Phase 2 |